SERB Specialty Pharmaceuticals
Manufacturing · Belgium · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Avenue Louise 480, Bruxelles Ixelles, Br...Phone Number
+33 173032000Website
www.serb.euRevenue
$60.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About SERB Specialty Pharmaceuticals
SERB Specialty Pharmaceuticals is a leading pan-European specialty pharmaceutical group, providing globally a reliable supply of prescription medicines to patient suffering from rare and life-threatening diseases. Following strategic acquisitions and targeted developments, SERB has succeeded in establishing a consistent drugs portfolio focused on niche specialty pharmaceuticals, to ensure continuous availability of life-saving medicines and answer unmet medical needs.Explore more
SERB Specialty Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SERB Specialty Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at SERB Specialty Pharmaceuticals
Funding: Get notified immidiatlly once SERB Specialty Pharmaceuticals has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on SERB Specialty Pharmaceuticals recently announced quarterly report
Product Launch: Get notified when SERB Specialty Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
SERB Specialty Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if SERB Specialty Pharmaceuticals is spiking on competitors!
Click to see if SERB Specialty Pharmaceuticals had a recent Job posting/layoffs
Check if SERB Specialty Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at SERB Specialty Pharmaceuticals
Find 3 more new buyers
Company Profile Activity
Activity Insights
SERB Specialty Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
SERB Specialty Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about SERB Specialty Pharmaceuticals.
SERB Specialty Pharmaceuticals Tech Stack
A closer look at the technologies used by SERB Specialty Pharmaceuticals
See more technologies
SERB Specialty Pharmaceuticals News & Media
SERB Pharmaceuticals licenses Soligenix antigen to develop ricin antidote
Philadelphia, July 14, 2022 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals has signed a worldwide exclusive license to use an antigen from Soligenix [NSDQ: SNGX] to develop a novel therapeutic treatment for ricin poisoning. There is an unmet need for protection against this highly potent toxin for which there is no vaccine or therapeutic intervention available.SERB Evaluation Consultant
Organization: Asian Disaster Preparedness Center Closing date: 30 Jun 2022 Purpose and Objectives: Background: The Asian Disaster Preparedness Center (ADPC), established in 1986, is a non-profit, autonomous international organization and non-political in management, staffing, and operations. ADPC has been created for scientific, educational, developmental, and humanitarian purposes that work to build the resilience of people and institutions to disasters and climate change impacts in Asia and thSERB, BTG Pharma name Kolaras as U.S. chief commercial officer - Medical, Marketing and Media
Kolaras brings more than 25 years of U.S. and global experience across large and mid-sized biopharma companies.Thomas Kolaras Joins SERB and BTG Specialty Pharmaceuticals as US Chief Commercial Officer
Philadelphia, April 11, 2022 (GLOBE NEWSWIRE) -- SERB and BTG Specialty Pharmaceuticals are pleased to announce that Thomas Kolaras has been named the group’s new Chief Commercial Officer for its US business.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SERB Specialty Pharmaceuticals
Sign Up For FreeTo access detailed company insights
SERB Specialty Pharmaceuticals is a leading pan-European specialty pharmaceutical group, providing globally a reliable supply of prescription medicines to patient suffering from rare and life-threatening diseases. Following strategic acquisitions and targeted developments, SERB has succeeded in establishing a consistent drugs portfolio focused on n... Read More
